| ICD-9-CM: |
| 146 - | Neoplasm, Oropharynx, Malignant |
| 146.0 - | Neoplasm, Tonsil, Malignant, NOS, Faucial, Palatine |
| 146.1 - | Neoplasm, Tonsillar Fossa, Malignant |
| 146.2 - | Neoplasm, Tonsillar Pillars, Malignant; Faucial Pillar; Glossopalatine Fold; Palatoglossal Arch; Palatopharyngeal Arch |
| 146.3 - | Neoplasm, Vallecula, Malignant |
| 146.4 - | Neoplasm, Anterior Aspect of Epiglottis, Malignant; Epiglottis, Free border; Glossoepiglottic Fold(s) |
| 146.5 - | Neoplasm, Junctional Region, Malignant |
| 146.6 - | Neoplasm, Lateral Wall of Oropharynx, Malignant |
| 146.7 - | Neoplasm, Posterior Wall of Oropharynx, Malignant |
| 146.8 - | Neoplasm, Other Specified Sites of Oropharynx, Malignant; Branchial Cleft |
| 146.9 - | Malignant Neoplasm, Oropharynx, Unspecified |
| 235.1 - | Neoplasm of Uncertain Behavior of Lip, Oral Cavity and Pharynx; Gingiva, Hypopharynx, Minor Salivary Glands, Mouth, Nasopharynx, Oropharynx, Tongue |
| Oral cavity cancer is the development of cancerous tumors on the lips, the inner lining (buccal mucosa) of the lips and cheeks, the front two-thirds of the tongue (oral tongue), the bottom of the mouth beneath the tongue, the bony roof of the mouth (hard palate), and the space behind the wisdom teeth (retromolar trigone). While there are a number of different cancers that can be found in the oral cavity, the most common is squamous cell carcinoma.
Oropharyngeal cancer is the development of cancerous tumors in the back part of the mouth or upper region of the throat. This includes the rear one-third (base) of the tongue, soft palate, tonsils and tonsillar pillars, and the rear wall of the throat (the posterior pharyngeal wall), which make up the oropharynx. Cancers in this region tend to develop open sores (ulcers) and may spread (metastasize) locally or throughout the body.
Cancer of the tongue is characterized by the progressive and uncontrolled growth of tongue cells. Up to 97% of tongue cancers are squamous cell carcinomas (Sharma 1451); other types are statistically uncommon. The tongue is divided into two separate anatomical areas: the oral tongue (the part that can be "stuck out," which extends back to a v-shaped group of lumps on the back of the tongue that are specialized taste buds), and the base of the tongue (behind these taste buds).
Most tongue cancers are found on the side (lateral margin) of the middle third of the oral tongue, and often extend onto the bottom (ventral aspect) of the oral tongue. Approximately 20% occur on the front (anterior) third of the lateral margin, and only about 4% of occur on the top surface (dorsum) or the tip of the oral tongue (Sharma 1451). The tongue has an extensive circulatory and lymphatic supply; consequently, cancer of the tongue can spread easily, and the prognosis for individuals with advanced tongue cancer is poor.
Cancers of the oral cavity or oropharynx (including the tongue) are treated according to what stage the cancer is in. This is determined by the size of tumor, whether the lymph nodes are involved, and whether the cancer has metastasized beyond the lymph nodes to distant organs.Risk: The greatest risk factor for cancer in the oral cavity is tobacco use, including smokeless tobacco. Smokers and those who drink a lot of alcohol are 6 times more likely to develop oral cavity or oropharyngeal cancer than nonusers ("Detailed Guide"). Other risk factors are poor oral hygiene with bacterial irritation, poor nutrition, immunosuppressed states and human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS). Individuals who work or recreate outdoors have a 30% increased risk for lip cancer ("Detailed Guide").
Risk factors for oropharyngeal cancer include tobacco use in any form, alcohol consumption, exposure to occupational health hazards (including man-made vitreous or wool fibers such as fiberglass and blown-in insulation, mustard gas, vinyl chloride polymers, isopropyl alcohol, hexavalent chromium, tannin extract, azo dyes, and aryl hydrocarbon hydroxylase), viral infections such as human papilloma virus, and genetic predisposition.
Men are nearly twice as likely to be affected as women by oral cavity and oropharyngeal cancer ("Detailed Guide"). Incidence and Prevalence: Oral cavity and oropharyngeal cancers are more common in blacks than in whites, and are generally found in individuals over the age of 35 ("Detailed Guide"). In the US in 2005 there will be 29,370 predicted new cases of oral cavity and oropharyngeal cancer, with 7,230 deaths; however, new diagnoses and mortality rates for oral cavity and oropharyngeal cancer have been falling over the last 20 years, possibly in part due to reduced tobacco use in the US ("Detailed Guide"). |
Source: Medical Disability Advisor
| History: Cancer of the oral cavity and oropharynx is often painless in its early stage. Individuals may complain of irritation in the throat and usually only report pain when the cancer develops into a crater-like (ulcerated) lesion. Individuals may also report a lump in the neck that represents spread (metastasis) of the cancer from the oropharynx. Individuals may also report a change in their voice, or persistent bad breath.
Cancer of the base of the tongue is usually quite advanced when diagnosed, because in the early stages it cannot be seen and creates few, if any symptoms. In some cases, the cancer will spread quickly into the lymphatic system, and the individual may report only a lump in the neck. Later in the course of the disease, an ulcerated lesion that is several centimeters in diameter may be found. The individual usually complains of increasing pain, a sense of fullness, changes in the voice, and speech and swallowing difficulty. The pain can be severe and constant and may radiate to the neck and ears. There may be a history of cancer on the lips, inside the cheeks, on the roof of the mouth, or in the upper throat area. Physical exam: Early stage oral cavity and oropharyngeal cancer may appear as small, apparently harmless areas of hardness or ulceration. Areas of tissue hardness (also referred to as areas of induration) or areas of ulceration usually represent tissue that is being infiltrated by a tumor. As the disease progresses, destruction of the inner lining in the back of the mouth or throat (erosion), redness or inflammation (erythema) of mucus membranes in the oropharynx, induration in normally soft throat tissues, oropharyngeal sores that do not heal (chronicity), hardening or enlargement of the nodes (lymphadenopathy), or white patches on the oropharyngeal mucosa (leukoplakia) are commonly observed. Eroded areas may appear ulcerated with irregular borders or raised edges. The individual may have enlarged, nontender lymph nodes in the neck.
In tongue cancer a grayish lesion (ulcer) in the bottom of a furrow (fissure) or on the surface of the oral tongue may be evident. Patchy areas (lesions) that can be white (leukoplakic) or pink to red (erythroplakia) may or may not be associated with the ulcer. Later in the course of the disease, the ulcer may be hard in consistency, with heaped-up (everted) edges. The floor of the ulcer may be grainy (granular) and hardened (indurated) and may bleed easily. There are often other areas of dying tissue (necrosis) on the tongue. Infiltration (metastasis) of the cancer into the lymphatic system is common in later stages, and many individuals will have enlarged nodes that are detectable by touch (palpable). Tests: Individual cells may be scraped from the lesion and observed microscopically to determine if they are cancerous (exfoliate cytology). If exfoliate cytology indicates that the cells are cancerous or if the lesion looks suspiciously like cancer, a small piece of tissue may be taken from the lesion (incisional biopsy) and examined microscopically to determine malignancy. The lymph nodes may be biopsied if it is still unclear whether the primary oropharyngeal lesion is cancerous. In this case, the entire lymph node can be removed (excisional biopsy) and tested. Alternatively, a fine needle aspiration biopsy is an accurate technique for identifying oropharyngeal lesions that have spread to the lymph nodes. After an oropharyngeal tumor is identified as cancer, CT or MRI can determine the extent of tumor growth. |
Source: Medical Disability Advisor
| Staging guides the treatment of oral cavity and oropharyngeal cancer. The primary forms of treatment useful in managing oropharyngeal cancer are surgery and/or radiation therapy. The treatment depends on the stage and site of the malignancy. In general, surgery is the treatment of choice for tumors not sensitive to radiation, recurrent tumors in the oropharynx previously irradiated, and in situations where the side effects of radiation are more severe than the defects produced by surgery.
Surgical treatment frequently involves removal (local excision or resection) of the tumor along with the associated lymph nodes (lymphectomy) that may contain cancer. The surgery should include removing at least 1 cm of healthy tissue around the lesion to ensure complete removal. If the tumor has spread to other areas of the mouth or jaw, these areas may also be removed. This surgery is often carried out in conjunction with removal of part of the neck and throat (radical neck dissection). Surgical treatment may have the disadvantage of sacrificing function of the vocal cords if the larynx is removed. If the cancer has spread to other areas of the mouth, cosmetically and functionally important structures such as the lip(s), lower jaw (mandible), and in some special cases, the eye, may be removed. If this is the case, artificial body parts (prostheses) are often used to reconstruct the face and mouth during surgery.
Radiation therapy is often used by itself for treatment of small and superficial oropharyngeal tumors that have not produced an abundance of dying tissue. Radiation is preferable in many cases when surgical removal of the cancer will result in severe morbidity. However, radiotherapy in the mouth area can also be debilitating as it may result in decreased salivary function and taste sensation, making it difficult for the individual to maintain weight and general condition.
Combination treatment using radiation therapy and surgery may be used if the cancerous lesion has metastasized, is large or deeply invasive, or if bone is involved. Combination treatment is often advantageous if the tumor has entered the lymph nodes since a greater number of cancerous lymphatic structures can be treated.
Chemotherapy by itself has not been used successfully to treat tongue cancer. However, it has been used in combination with surgery or radiation therapy. It may be used to shrink cancer before surgery or radiation therapy (Neoadjuvant chemotherapy) or as a treatment to moderate the intensity of the disease (palliative treatment).
A support system consisting of a clinical social worker and a vocational rehabilitation counselor is usually necessary throughout the course of treatment until recovery is complete. |
Source: Medical Disability Advisor
| The predicted outcome of tongue cancer varies, depending upon the stage of the lesion and the adequacy of the initial treatment. Early detection and prompt treatment with radiation therapy produces a 5-year survival rate of 80% to 90%; 5-year survival rates for more advanced tongue cancer (stages III and IV) range from 30% to 50% if lymph nodes are not involved, and 15% to 30% if they are (Gosselin). The possibility of disease recurrence is increased considerably in individuals who smoke or chew tobacco. In more advanced tumors, recurrence may happen in 39% of cases. The outcome for advanced tumors is poor if the cancer involves large areas of the tongue, or if there have been metastases into the lymphatic system or other tissues. |
Source: Medical Disability Advisor
| If surgery is required for the removal of a tumor, rehabilitation following excision is often prescribed as the individual may experience voice and swallowing dysfunction. Rehabilitation for oral cavity or oropharynx cancer requires a team approach to include a clinical social worker and a vocational rehabilitation counselor. Occupational therapists and speech pathologists treat individuals with muscle dysfunction by retraining altered facial muscles affected by the disease and/or treatment, and retraining swallowing function. Dental professionals may also be involved with individuals with oropharynx cancer.
The rehabilitation program may need modifications based on the various degrees of oropharynx cancer. Modifications are also made when surgery is required. The extent of surgery affects the nature and the progression of the rehabilitation. |
Source: Medical Disability Advisor
| Complications of oral cavity and oropharyngeal cancer may include local infections (sepsis) and bleeding, general infections (septicemia or pneumonia), loss of appetite (anorexia), weight loss (cachexia), low hemoglobin content in the blood (anemia), and abnormal enlargement of neck, jaw, and facial features due to tumor growth. Severe bleeding (hemorrhage) may also occur as a result of the tumor destroying blood vessels that lie in close proximity. The tumor can metastasize into the lymph system, causing Hodgkin's disease, non-Hodgkin's lymphoma, Burkitt's lymphoma, or multiple myeloma to develop.
Cancer of the tongue may be complicated if it spreads to other areas of the mouth and throat because large tumors may impair tongue function by creating rigidity in tongue muscles. Following removal of a cancerous lesion from the tongue, secondary lesions have occurred to a higher extent in individuals infected with human papillomavirus (HPV) and women who have cervical cancer. |
Source: Medical Disability Advisor
| Most individuals require more sedentary work for a period of time due to weakness and fatigue following surgery, radiation therapy, or chemotherapy. Frequent breaks may be needed, and heavy or prolonged physical exertion may have to be avoided until recovery is complete. Accommodations may have to be made for individuals with restricted vocal capabilities following treatment and who must use their voice in the workplace. Accommodations may also be necessary for individuals with swallowing difficulties following surgical treatment. In the absence of other medical complications and with these accommodations in effect, individuals treated for oropharyngeal cancer should be able to return to their previous duties after a period of recovery. |
Source: Medical Disability Advisor
| If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case. Regarding diagnosis:
- Was diagnosis of oral cavity or oropharyngeal cancer confirmed through exfoliate cytology, incisional biopsy, and/or lymph node biopsy?
-
After an oropharyngeal tumor is identified as cancer, was CT or MRI performed to determine the extent of tumor growth?
-
Has the tumor metastasized into the lymph system?
-
Does individual have cervical cancer or human papillomavirus (HPV) infection?
-
Does individual have poor oral hygiene?
-
Has individual had persistent physical trauma to the tongue?
-
Does individual use tobacco in any form? Consume alcohol or spicy food?
-
Does individual have syphilis? Cirrhosis of the liver? AIDS?
-
Is an ulcerated lesion on the tongue present?
-
Does individual have pain or a sense of fullness?
-
Did individual's voice change? Is speech difficult?
-
Has individual experienced trouble swallowing?
-
Does individual have severe and constant pain? Does it radiate?
-
Does individual have a history of cancer anywhere near the tongue?
-
Does individual have diabetes or hypertension also associated with erosive OLP that may be precancerous in nature?
-
Were other conditions such as fibroma, lipoma, neurofibroma, hemangioma, and various herpesviruses that produce cold sores in the mouth ruled out?
Regarding treatment:
- Was surgery the treatment of choice? If so, were prostheses used to reconstruct the face and mouth during surgery? Is additional reconstruction anticipated?
-
Would individual benefit from the addition of radiation therapy to current treatment plan?
-
If radiation therapy was the treatment, what is being done to counteract the side effects of decreasing salivary function and taste sensation making if difficult for individual to maintain weight and general condition?
-
Is a support system in place consisting of a clinical social worker and a vocational rehabilitation counselor? Has individual taken advantage of these services?
-
Was chemotherapy used with surgery and radiation? As palliative treatment?
Regarding prognosis:
- At what stage was the cancer detected?
-
Was treatment started promptly?
-
Has the cancer recurred?
-
How are individual's general health, coping abilities, and tobacco and alcohol use?
-
What has individual done to modify risk factors?
-
Does individual have another underlying condition such as diabetes or hypertension that may impact recovery?
-
Have complications developed such as local infections and bleeding, general infections (septicemia or pneumonia), anorexia, weight loss, anemia, and abnormal enlargement of neck, jaw, and facial features due to tumor growth?
-
Has individual experienced any other complications as a result of the oropharyngeal cancer?
-
Would individual benefit from additional psychological or vocational counseling?
-
Is individual active in a rehabilitation program?
-
Can individual's employer accommodate any necessary restrictions?
-
At what stage was the tumor diagnosed and treated?
-
Has individual developed complications such as oral infections or bleeding, general infections (septicemia or pneumonia), dental disease, loss of appetite, weight loss, facial paralysis, loss of chewing ability, anemia or abnormal enlargement of jaw and facial features due to tumor growth?
|
Source: Medical Disability Advisor
| "Detailed Guide: Oral Cavity and Oropharyngeal Cancer." American Cancer Society. 22 Sep. 2004 <http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?rnav=cridg&dt=60>.Gosselin, Benoit J. "Malignant Tumors of the Mobile Tongue." eMedicine. Eds. William M. Lydiatt, et al. 19 Aug. 2004. Medscape. 3 Feb. 2005 <http//emedicine.com/ent/topic256.htm>. Sharma, Pramod K., David E. Schuller, and Shan R. Baker. "Malignant Neoplasms of the Oral Cavity." Otolaryngology: Head and Neck Surgery. Ed. T. J. Cummings. 3rd ed. 5 vols. St. Louis: Mosby-Year Book, Inc., 1998. 1418-1460. |
Source: Medical Disability Advisor
| Feedback |
| Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must
include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment.
If you are seeking medical advice, please contact your physician. Thank you! |
Send this comment to:
Sales
Customer Support
Content Development
|
|
| |
|
|
|
|
|
This publication is designed to provide accurate and authoritative information in
regard to the subject matter covered. It is published with the understanding that
the author, editors, and publisher are not engaged in rendering medical, legal,
accounting or other professional service. If medical, legal, or other expert assistance
is required, the service of a competent professional should be sought. We are unable to respond to requests for advice.
Any Sales inquiries should include an email address or other means of
communication.
|